HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 47671,
"recordsTotal": 47671,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-days_late&start=44700",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-days_late&start=44100",
"results": [
{
"registry_id": "NCT06107062",
"publication_url": "https://clinicaltrials.gov/study/NCT06107062",
"title": "Hemp-derived Cannabidiol for the Treatment of Cannabis Use Disorder: A Double-blind Placebo-controlled Randomized Trial",
"has_exemption": false,
"start_date": "2024-05-16",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05861986",
"publication_url": "https://clinicaltrials.gov/study/NCT05861986",
"title": "A Phase IV Open-Label Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Patients With Spinal Muscular Atrophy After Gene Therapy",
"has_exemption": false,
"start_date": "2024-05-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06483334",
"publication_url": "https://clinicaltrials.gov/study/NCT06483334",
"title": "A Phase 1/2 Randomized, Umbrella Study to Evaluate the Efficacy and Safety of MK-2870 Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab, as Treatment for Participants With Advanced Urothelial Carcinoma (KEYMAKER-U04): Substudy 04C",
"has_exemption": false,
"start_date": "2024-07-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06428019",
"publication_url": "https://clinicaltrials.gov/study/NCT06428019",
"title": "A Prospective, Open-Label, Phase IIb/III Study to Evaluate the Risk of TLS and Optimization of the Initiation of Venetoclax in Combination With Obinutuzumab or Acalabrutinib With Different Ramp- Up Periods in Previously Untreated Subjects With CLL",
"has_exemption": false,
"start_date": "2024-08-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06442566",
"publication_url": "https://clinicaltrials.gov/study/NCT06442566",
"title": "Sequential Trial of Adding Buprenorphine, Cognitive Behavioral Treatment, and Transcranial Magnetic Stimulation to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain (ACTION)",
"has_exemption": false,
"start_date": "2024-08-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05861999",
"publication_url": "https://clinicaltrials.gov/study/NCT05861999",
"title": "A Phase IV Open-Label Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy",
"has_exemption": false,
"start_date": "2024-08-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06033950",
"publication_url": "https://clinicaltrials.gov/study/NCT06033950",
"title": "A Randomized, Double-blind, Placebo-controlled Pragmatic Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure and Reduced Ejection Fraction Who Are Intolerant of or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists (FINALITY-HF)",
"has_exemption": false,
"start_date": "2024-08-20",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Colorado Prevention Center",
"sponsor_slug": "colorado-prevention-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06096116",
"publication_url": "https://clinicaltrials.gov/study/NCT06096116",
"title": "Phase 3, Double-blind, Placebo-controlled, Multicentre Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass",
"has_exemption": false,
"start_date": "2024-08-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Octapharma",
"sponsor_slug": "octapharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05667701",
"publication_url": "https://clinicaltrials.gov/study/NCT05667701",
"title": "Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study",
"has_exemption": false,
"start_date": "2024-09-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rajesh Kumar",
"sponsor_slug": "rajesh-kumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06184750",
"publication_url": "https://clinicaltrials.gov/study/NCT06184750",
"title": "Refining Tamoxifen Dose for Premenopausal Breast Cancer Risk Reduction (RENAISSANCE): A Phase II Single Arm Trial",
"has_exemption": false,
"start_date": "2024-09-27",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679270",
"publication_url": "https://clinicaltrials.gov/study/NCT06679270",
"title": "An Open-label Extension of APG-20 Study to Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With Partial Lipodystrophy",
"has_exemption": false,
"start_date": "2024-10-14",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amryt Pharma",
"sponsor_slug": "amryt-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04530058",
"publication_url": "https://clinicaltrials.gov/study/NCT04530058",
"title": "The Effects of Metformin on Morbidity and Mortality in Elderly Patients- a Prospective Randomized Control Trial (RCT)",
"has_exemption": false,
"start_date": "2024-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hamilton Health Sciences Corporation",
"sponsor_slug": "hamilton-health-sciences-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06272812",
"publication_url": "https://clinicaltrials.gov/study/NCT06272812",
"title": "A Phase 2b, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine, MTBVAC, Against TB Disease in Interferon Gamma Release Assay Positive Adolescents and Adults Aged 14-45 Years, Living in a TB Endemic Region.",
"has_exemption": false,
"start_date": "2025-02-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "International AIDS Vaccine Initiative",
"sponsor_slug": "international-aids-vaccine-initiative",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855212",
"publication_url": "https://clinicaltrials.gov/study/NCT06855212",
"title": "A Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-02-26",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06830044",
"publication_url": "https://clinicaltrials.gov/study/NCT06830044",
"title": "A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Milsaperidone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-03-03",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanda Pharmaceuticals",
"sponsor_slug": "vanda-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06311214",
"publication_url": "https://clinicaltrials.gov/study/NCT06311214",
"title": "Optimizing Antibody-Drug Conjugate Therapy Through Molecular Analysis for Therapy Choice (ADC MATCH)",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06812832",
"publication_url": "https://clinicaltrials.gov/study/NCT06812832",
"title": "Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol",
"has_exemption": false,
"start_date": "2025-04-08",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Madigan Army Medical Center",
"sponsor_slug": "madigan-army-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820463",
"publication_url": "https://clinicaltrials.gov/study/NCT06820463",
"title": "A Phase 2, Open-Label, Randomized, Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations With Telisotuzumab Adizutecan in Subjects With Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-04-24",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06579196",
"publication_url": "https://clinicaltrials.gov/study/NCT06579196",
"title": "Evaluation of Trabedersen (OT-101) With Pembrolizumab in Patients With Newly Diagnosed Advanced Non-Small Cell Lung Cancer and Positive PD-L1",
"has_exemption": false,
"start_date": "2025-05-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Nebraska",
"sponsor_slug": "university-of-nebraska",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06702553",
"publication_url": "https://clinicaltrials.gov/study/NCT06702553",
"title": "Effect of Inhaled Nitric Oxide on Major Adverse Events Requiring Intensive Life Support in Adults Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Phase III, Double-Blind, Multicenter, Randomized Controlled Trial (Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass, the NORISC Trial)",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Xijing Hospital",
"sponsor_slug": "xijing-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06485843",
"publication_url": "https://clinicaltrials.gov/study/NCT06485843",
"title": "An Open Label Phase IIb Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ageless Biotech, Inc.",
"sponsor_slug": "ageless-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06682988",
"publication_url": "https://clinicaltrials.gov/study/NCT06682988",
"title": "A Randomized Phase 2, Open-label Study of Mirvetuximab Soravtansine in Patients With Platinum-resistant Advanced High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-alpha Expression Testing 2 Schedules of Administration for Dose Optimization, With a Separate Cohort to Determine Starting Dose in Patients With Moderate Hepatic Impairment",
"has_exemption": false,
"start_date": "2025-05-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06340568",
"publication_url": "https://clinicaltrials.gov/study/NCT06340568",
"title": "A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator's Choice of Chemotherapy in Previously Treated Patients With HER2- Expressing Recurrent Endometrial Cancer",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07075718",
"publication_url": "https://clinicaltrials.gov/study/NCT07075718",
"title": "Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Glaukos Corporation",
"sponsor_slug": "glaukos-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06951594",
"publication_url": "https://clinicaltrials.gov/study/NCT06951594",
"title": "Iowa Cochlear Implant Clinical Research Center Study on Robotic-Assisted Versus Manual Electrode Array Insertion",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07045909",
"publication_url": "https://clinicaltrials.gov/study/NCT07045909",
"title": "A Phase 2, Open-label, Multicenter Multi-cohort Study to Evaluate the Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "PETHEMA Foundation",
"sponsor_slug": "pethema-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06356155",
"publication_url": "https://clinicaltrials.gov/study/NCT06356155",
"title": "A Phase II, Open-label, Single-arm, Multi-center Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer (NEPTUNE)",
"has_exemption": false,
"start_date": "2025-07-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan Rogel Cancer Center",
"sponsor_slug": "university-of-michigan-rogel-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06850805",
"publication_url": "https://clinicaltrials.gov/study/NCT06850805",
"title": "A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 mcg of OPN-375 Twice a Day (BID) in Adolescent Subjects With Chronic Rhinosinusitis Without Nasal Polyps",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Optinose US Inc.",
"sponsor_slug": "optinose-us-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06070012",
"publication_url": "https://clinicaltrials.gov/study/NCT06070012",
"title": "Phase II Open-label, Multi-center Study of Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma (mUM) With Integrated Circulating Tumor DNA (ctDNA) Biomarker (TARGET-tebe)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959524",
"publication_url": "https://clinicaltrials.gov/study/NCT06959524",
"title": "AGENT DCB STANCE: AGENT Drug-Coated Balloon for STent AvoidANCE in PCI for De Novo Coronary Artery Disease",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07114380",
"publication_url": "https://clinicaltrials.gov/study/NCT07114380",
"title": "Investigation of Cold Snare Polypectomy for Removing 10-20 mm 0-Ip Colorectal Polyp: One Feasibility and Safety Study",
"has_exemption": false,
"start_date": "2025-08-25",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Taiwan University Hospital",
"sponsor_slug": "national-taiwan-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023835",
"publication_url": "https://clinicaltrials.gov/study/NCT07023835",
"title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Usnoflast Administered to Adult Subjects With ALS",
"has_exemption": false,
"start_date": "2025-09-17",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zydus Therapeutics Inc.",
"sponsor_slug": "zydus-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07202884",
"publication_url": "https://clinicaltrials.gov/study/NCT07202884",
"title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07181837",
"publication_url": "https://clinicaltrials.gov/study/NCT07181837",
"title": "A Multi-Center, Open-label, Phase 1/2 Trial of the Safety and Efficacy of MVX-220 Gene Therapy Administered by Intra-Cisterna Magna Injection to Participants With Angelman Syndrome",
"has_exemption": false,
"start_date": "2025-10-29",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "MavriX Bio, LLC",
"sponsor_slug": "mavrix-bio-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06708455",
"publication_url": "https://clinicaltrials.gov/study/NCT06708455",
"title": "Phase 2 Trial of Autologous Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy of PD-(L)1 Resistant Malignant Melanoma",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapa Therapeutics LLC",
"sponsor_slug": "rapa-therapeutics-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06699121",
"publication_url": "https://clinicaltrials.gov/study/NCT06699121",
"title": "A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Study Evaluating the Safety and Efficacy of LB P8 in Patients With Primary Sclerosing Cholangitis (PSC)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "LISCure Biosciences",
"sponsor_slug": "liscure-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205601",
"publication_url": "https://clinicaltrials.gov/study/NCT07205601",
"title": "Phase 2a Assessment of Safety, Tolerability, and Efficacy of Repeated Dosing of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild to Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneration Biomedical, Inc.",
"sponsor_slug": "regeneration-biomedical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06917313",
"publication_url": "https://clinicaltrials.gov/study/NCT06917313",
"title": "A Randomized Phase II Study to Evaluate the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy",
"has_exemption": false,
"start_date": "2025-12-05",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722183",
"publication_url": "https://clinicaltrials.gov/study/NCT06722183",
"title": "FUTURE Platform Trial - A Phase II Platform Trial of Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest",
"sponsor_slug": "institut-fur-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225712",
"publication_url": "https://clinicaltrials.gov/study/NCT07225712",
"title": "A Multicenter, Uncontrolled, Open-label Trial to Evaluate the Tolerability, Safety, and Efficacy of Long-term Administration of SEP-363856 in Patients With Schizophrenia",
"has_exemption": false,
"start_date": "2025-12-22",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Co., Ltd.",
"sponsor_slug": "otsuka-pharmaceutical-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07183319",
"publication_url": "https://clinicaltrials.gov/study/NCT07183319",
"title": "Circulating Tumor DNA Response Adapted Treatment De-escalation Metastatic Urothelial Carcinoma (CT-READ)",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219602",
"publication_url": "https://clinicaltrials.gov/study/NCT07219602",
"title": "A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of Obicetrapib 10 mg and Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome (RUBENS Trial)",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NewAmsterdam Pharma",
"sponsor_slug": "newamsterdam-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04901741",
"publication_url": "https://clinicaltrials.gov/study/NCT04901741",
"title": "An Open-label Phase 2 Study of Olaptesed Pegol (NOX-A12) Combined With Pembrolizumab and Nanoliposomal Irinotecan/5-FU/Leucovorin or Gemcitabine/Nab-paclitaxel in Microsatellite-stable Metastatic Pancreatic Cancer Patients",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TME Pharma AG",
"sponsor_slug": "tme-pharma-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06842498",
"publication_url": "https://clinicaltrials.gov/study/NCT06842498",
"title": "A Phase 2 Dose Optimization Trial Evaluating a CD46-Targeted Antibody-Drug Conjugate (FG-3246) in Patients With Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyntra Bio",
"sponsor_slug": "kyntra-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07322003",
"publication_url": "https://clinicaltrials.gov/study/NCT07322003",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants With Amyotrophic Lateral Sclerosis",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prilenia",
"sponsor_slug": "prilenia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07321886",
"publication_url": "https://clinicaltrials.gov/study/NCT07321886",
"title": "A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, Without Type 2 Diabetes",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06067802",
"publication_url": "https://clinicaltrials.gov/study/NCT06067802",
"title": "A Phase II, Escalating Dose, Open Label Study to Evaluate the Safety of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jerry Vockley, MD, PhD",
"sponsor_slug": "jerry-vockley-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07258407",
"publication_url": "https://clinicaltrials.gov/study/NCT07258407",
"title": "A Phase 1/2 Dose Escalation Trial With Administration Schedule Exploration Evaluating Single Agent TD001, a PSMA-Targeted Antibody-Drug Conjugate, in Patients With PSMA-Expressing Metastatic Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "T.O.A.D. Oncology SA",
"sponsor_slug": "toad-oncology-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07353931",
"publication_url": "https://clinicaltrials.gov/study/NCT07353931",
"title": "A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Osteoarthritis Knee Pain, and Obesity or Overweight (ENLIGHTEN-4)",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07208760",
"publication_url": "https://clinicaltrials.gov/study/NCT07208760",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of L9LS on R21/Matrix-M™ Vaccine Immunogenicity",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07249554",
"publication_url": "https://clinicaltrials.gov/study/NCT07249554",
"title": "Preliminary Safety and Efficacy of Semaglutide and Naltrexone Combination Therapy for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339358",
"publication_url": "https://clinicaltrials.gov/study/NCT07339358",
"title": "Safety & Performance of the World Medica World Diverter Embolization Device",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "World Medica USA, LLC",
"sponsor_slug": "world-medica-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07369011",
"publication_url": "https://clinicaltrials.gov/study/NCT07369011",
"title": "A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Moderate to Severe Obstructive Sleep Apnea, and Obesity or Overweight",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07263230",
"publication_url": "https://clinicaltrials.gov/study/NCT07263230",
"title": "An Open-label Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Subjects With Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07304102",
"publication_url": "https://clinicaltrials.gov/study/NCT07304102",
"title": "Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "W.L.Gore & Associates",
"sponsor_slug": "wlgore-associates",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05402384",
"publication_url": "https://clinicaltrials.gov/study/NCT05402384",
"title": "Evaluation of Efficacy and Safety of D-galactose Supplementation in SLC35A2-CDG, a Disorder of Hypogalactosylation",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2028-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eva Morava-Kozicz",
"sponsor_slug": "eva-morava-kozicz",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03678025",
"publication_url": "https://clinicaltrials.gov/study/NCT03678025",
"title": "Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2018-09-24",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03947450",
"publication_url": "https://clinicaltrials.gov/study/NCT03947450",
"title": "Autologous Volar Fibroblast Injection Into the Stump Site of Amputees",
"has_exemption": false,
"start_date": "2019-09-05",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03984448",
"publication_url": "https://clinicaltrials.gov/study/NCT03984448",
"title": "Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas",
"has_exemption": false,
"start_date": "2019-10-22",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05764642",
"publication_url": "https://clinicaltrials.gov/study/NCT05764642",
"title": "Renal Microvessel Imaging for Characterization of Chronic Kidney Disease",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06062875",
"publication_url": "https://clinicaltrials.gov/study/NCT06062875",
"title": "Effects of TNF Blockade on Human BPH/LUTS",
"has_exemption": false,
"start_date": "2024-01-24",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Endeavor Health",
"sponsor_slug": "endeavor-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06073665",
"publication_url": "https://clinicaltrials.gov/study/NCT06073665",
"title": "Levothyroxine Dosing in Older Individuals",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06350045",
"publication_url": "https://clinicaltrials.gov/study/NCT06350045",
"title": "Renal Puncture Above the Eleventh Rib (High Supracostal Approach) Versus Subcostal Puncture in Percutaneous Nephrolithotomy for Treatment of Renal Stones in Adults: A Prospective Randomized Trial",
"has_exemption": false,
"start_date": "2024-03-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Assiut University",
"sponsor_slug": "assiut-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06150417",
"publication_url": "https://clinicaltrials.gov/study/NCT06150417",
"title": "Metastasis-directed Radiotherapy (MDRT) for Men With De-novo Oligometastatic Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Case Comprehensive Cancer Center",
"sponsor_slug": "case-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06150599",
"publication_url": "https://clinicaltrials.gov/study/NCT06150599",
"title": "Sacral Neuromodulation for the Treatment of Chronic Pelvic Pain",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Corewell Health East",
"sponsor_slug": "corewell-health-east",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07212062",
"publication_url": "https://clinicaltrials.gov/study/NCT07212062",
"title": "A Phase II, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Sfatey and Tolerability of X/T+X-EC vs. Placebo in Participants With Alzheimer's Disease Currently Treated With Lecanemab.",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurology Office of South Florida",
"sponsor_slug": "neurology-office-of-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06853223",
"publication_url": "https://clinicaltrials.gov/study/NCT06853223",
"title": "A Randomized Trial of CCR5 Inhibition as a Complement to Lung Transplant Induction Immunosuppression",
"has_exemption": false,
"start_date": "2025-12-07",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285473",
"publication_url": "https://clinicaltrials.gov/study/NCT07285473",
"title": "Low-dose Naltrexone (LDN) for the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Dose-Finding",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339163",
"publication_url": "https://clinicaltrials.gov/study/NCT07339163",
"title": "Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval (ISI) for Adults With Recurrent Respiratory Papillomatosis (RRP)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06822010",
"publication_url": "https://clinicaltrials.gov/study/NCT06822010",
"title": "A Phase II Trial of SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma (SUMMIT)",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227857",
"publication_url": "https://clinicaltrials.gov/study/NCT07227857",
"title": "A Phase Ib/II First-in-human, Multicentre, Open-label, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effect of Intrathecal S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2028-04-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Recherches Internationales Servier",
"sponsor_slug": "institut-de-recherches-internationales-servier",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224477",
"publication_url": "https://clinicaltrials.gov/study/NCT07224477",
"title": "A Phase 2, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V540A in Healthy Females 16 to 26 Years of Age",
"has_exemption": false,
"start_date": "2026-07-20",
"completion_date": "2028-04-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05719441",
"publication_url": "https://clinicaltrials.gov/study/NCT05719441",
"title": "A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission",
"has_exemption": false,
"start_date": "2024-08-19",
"completion_date": "2028-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06646276",
"publication_url": "https://clinicaltrials.gov/study/NCT06646276",
"title": "A Randomized, Double Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012+Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide vs Atezolizumab in Combination With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2028-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06919965",
"publication_url": "https://clinicaltrials.gov/study/NCT06919965",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Investigator's Choice of Intravesical Chemotherapy in Participants With High-risk Non-muscle-invasive Bladder Cancer With Susceptible FGFR Alterations Who Had Received Intravesical Bacillus Calmette-Guérin (BCG)",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2028-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05849298",
"publication_url": "https://clinicaltrials.gov/study/NCT05849298",
"title": "An International Prospective Open-label, Multi-center, Randomized, Non-comparative Phase II Study of Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) Alone and Lutetium [177Lu] Vipivotide Tetraxetan (AAA617) in Combination With Androgen Receptor Pathway Inhibitors in Patients With PSMA PET Scan Positive Castration-Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2024-01-03",
"completion_date": "2028-04-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07202247",
"publication_url": "https://clinicaltrials.gov/study/NCT07202247",
"title": "A Phase II Randomized Study of Interventions for Metabolic Protection Against Cardiometabolic Toxicity During Androgen Deprivation Therapy (IMPACT-ADT)",
"has_exemption": false,
"start_date": "2025-12-08",
"completion_date": "2028-04-09",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06784726",
"publication_url": "https://clinicaltrials.gov/study/NCT06784726",
"title": "Odronextamab for Relapsed/Refractory Large B-cell Lymphomas Before Definitive Lymphoma-Directed Therapies",
"has_exemption": false,
"start_date": "2025-09-04",
"completion_date": "2028-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07231952",
"publication_url": "https://clinicaltrials.gov/study/NCT07231952",
"title": "A Phase II Study of Time-limited Combination of Pirtobrutinib, Venetoclax, and Rituximab in Treatment Naïve Patients With Waldenström's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) (PRoVen)",
"has_exemption": false,
"start_date": "2025-11-11",
"completion_date": "2028-04-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05156983",
"publication_url": "https://clinicaltrials.gov/study/NCT05156983",
"title": "A Phase 3, Prospective, Randomized, Open-label, Adaptive Group Sequential, Multicenter Trial With Blinded Endpoint Assessment to Evaluate the Efficacy and Safety of TAK-330 for the Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation in Patients Requiring Urgent Surgery/Invasive Procedure",
"has_exemption": false,
"start_date": "2022-08-24",
"completion_date": "2028-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260683",
"publication_url": "https://clinicaltrials.gov/study/NCT06260683",
"title": "A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-Cigarettes on Smoking Behavior",
"has_exemption": false,
"start_date": "2024-04-10",
"completion_date": "2028-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University Comprehensive Cancer Center",
"sponsor_slug": "ohio-state-university-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06668181",
"publication_url": "https://clinicaltrials.gov/study/NCT06668181",
"title": "Open-Label, Single-Arm Trial to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants From 2 to Less Than 18 Years of Age With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-Related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2025-03-11",
"completion_date": "2028-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332455",
"publication_url": "https://clinicaltrials.gov/study/NCT07332455",
"title": "A Phase 1/2 First-Time-in-Human, Open-label, Multicenter, Dose Escalation and Dose Optimization Study of GSK5471713 in Adult Participants With Metastatic Castration Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2028-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07042438",
"publication_url": "https://clinicaltrials.gov/study/NCT07042438",
"title": "A Phase 2 Randomized Trial of Remodeling Intestinal Microbiota Using Fecal Microbiome Transplant (FMT) Among Recipients of Chimeric Antigen Receptor T Cells (CAR T)",
"has_exemption": false,
"start_date": "2026-01-17",
"completion_date": "2028-04-13",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07023432",
"publication_url": "https://clinicaltrials.gov/study/NCT07023432",
"title": "Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2028-04-14",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04515836",
"publication_url": "https://clinicaltrials.gov/study/NCT04515836",
"title": "Phase II Trial of Olaparib in Homologous Recombination Deficient (HRD) Malignant Mesothelioma",
"has_exemption": false,
"start_date": "2021-02-19",
"completion_date": "2028-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04988386",
"publication_url": "https://clinicaltrials.gov/study/NCT04988386",
"title": "An Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Participants With Symptomatic Transthyretin Amyloid Cardiomyopathy Who Completed the Phase 3 ATTRibute-CM Trial (AG10-301)",
"has_exemption": false,
"start_date": "2021-10-27",
"completion_date": "2028-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Eidos Therapeutics, a BridgeBio company",
"sponsor_slug": "eidos-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07156578",
"publication_url": "https://clinicaltrials.gov/study/NCT07156578",
"title": "A Long-Term, Open-Label Extension Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2028-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Rhythm Pharmaceuticals, Inc.",
"sponsor_slug": "rhythm-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05859568",
"publication_url": "https://clinicaltrials.gov/study/NCT05859568",
"title": "Baseline Performance and Fitting Parameters for Sonova Products",
"has_exemption": false,
"start_date": "2023-04-17",
"completion_date": "2028-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Advanced Bionics",
"sponsor_slug": "advanced-bionics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06973187",
"publication_url": "https://clinicaltrials.gov/study/NCT06973187",
"title": "A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2025-09-04",
"completion_date": "2028-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07130903",
"publication_url": "https://clinicaltrials.gov/study/NCT07130903",
"title": "A Phase 2 Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2028-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Barbara Ann Karmanos Cancer Institute",
"sponsor_slug": "barbara-ann-karmanos-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06129864",
"publication_url": "https://clinicaltrials.gov/study/NCT06129864",
"title": "A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy (eVOLVE-HNSCC)",
"has_exemption": false,
"start_date": "2023-12-14",
"completion_date": "2028-04-18",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907615",
"publication_url": "https://clinicaltrials.gov/study/NCT06907615",
"title": "An Open-label, Multi-center, Global Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)",
"has_exemption": false,
"start_date": "2025-06-09",
"completion_date": "2028-04-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Henlius Biotech",
"sponsor_slug": "shanghai-henlius-biotech",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05984277",
"publication_url": "https://clinicaltrials.gov/study/NCT05984277",
"title": "A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC).",
"has_exemption": false,
"start_date": "2023-10-24",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06357533",
"publication_url": "https://clinicaltrials.gov/study/NCT06357533",
"title": "A Phase III, Randomised, Open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Monotherapy Versus Pembrolizumab Monotherapy for the First-line Treatment of Participants With Locally-advanced or Metastatic Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations (TROPION-Lung10)",
"has_exemption": false,
"start_date": "2024-04-11",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788938",
"publication_url": "https://clinicaltrials.gov/study/NCT06788938",
"title": "Tarlatamab in Advanced DLL3-Expressing Tumors Including Neuroendocrine Neoplasms",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06911502",
"publication_url": "https://clinicaltrials.gov/study/NCT06911502",
"title": "A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) Vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2028-04-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05536349",
"publication_url": "https://clinicaltrials.gov/study/NCT05536349",
"title": "Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2028-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05939414",
"publication_url": "https://clinicaltrials.gov/study/NCT05939414",
"title": "An International, Prospective, Open-label, Multi-center, Randomized Phase III Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) Versus Observation to Delay Castration or Disease Recurrence in Adult Male Patients With Prostate-specific Membrane Antigen (PSMA) Positive Oligometastatic Prostate Cancer (OMPC)",
"has_exemption": false,
"start_date": "2024-03-12",
"completion_date": "2028-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07109219",
"publication_url": "https://clinicaltrials.gov/study/NCT07109219",
"title": "A Modular Phase I/II, Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of AZD4512 Monotherapy or in Combination With Anticancer Agent(s) in Participants With Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2028-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218354",
"publication_url": "https://clinicaltrials.gov/study/NCT07218354",
"title": "CSP #2041 - Cessation or Reduction of Alcohol Consumption in VEterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder (CRAVE)",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06071767",
"publication_url": "https://clinicaltrials.gov/study/NCT06071767",
"title": "A Phase I/IIa Randomized, Placebo-Controlled Trial of Conserved-Mosaic T-cell Vaccine in a Regimen With Vesatolimod and Broadly Neutralizing Antibodies in Adults Initiated on Suppressive Antiretroviral Therapy During Acute HIV-1",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2028-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06358872",
"publication_url": "https://clinicaltrials.gov/study/NCT06358872",
"title": "Azithromycine Pour la Vie Des Enfants au Niger II",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01760005",
"publication_url": "https://clinicaltrials.gov/study/NCT01760005",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2012-12-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02718001",
"publication_url": "https://clinicaltrials.gov/study/NCT02718001",
"title": "Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)",
"has_exemption": false,
"start_date": "2015-02-06",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03128996",
"publication_url": "https://clinicaltrials.gov/study/NCT03128996",
"title": "A Phase I/II Trial of Reduced Intensity Conditioning and Familial HLA-Mismatched Bone Marrow Transplantation in Children With Non-Malignant Disorders",
"has_exemption": false,
"start_date": "2017-03-20",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04089059",
"publication_url": "https://clinicaltrials.gov/study/NCT04089059",
"title": "A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)",
"has_exemption": false,
"start_date": "2020-01-10",
"completion_date": "2028-04-30",
"has_results": true,
"results_due": false,
"sponsor_name": "Endotronix, Inc.",
"sponsor_slug": "endotronix-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04725474",
"publication_url": "https://clinicaltrials.gov/study/NCT04725474",
"title": "A Phase 1/2, FIH, Two-part, Open-label Clinical Trial of Intravenous (IV) Administration of CTL-002 Given as Monotherapy and/or in Combination With an Anti-PD-1 Checkpoint Inhibitor in Subjects With Advanced-stage, Relapsed/Refractory Solid Tumors (The \"GDFATHER\"-Trial: GDF-15 Antibody-mediaTed Human Effector Cell Relocation).",
"has_exemption": false,
"start_date": "2020-12-09",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "CatalYm GmbH",
"sponsor_slug": "catalym-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04862286",
"publication_url": "https://clinicaltrials.gov/study/NCT04862286",
"title": "OptIMMize-2: A Phase 3 Multicenter, Single-arm, Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of Risankizumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Completed Participation in Study M19-977 (OptIMMize-1)",
"has_exemption": false,
"start_date": "2021-07-24",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05164172",
"publication_url": "https://clinicaltrials.gov/study/NCT05164172",
"title": "Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine",
"has_exemption": false,
"start_date": "2021-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lundbeck A/S",
"sponsor_slug": "h-lundbeck-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05269394",
"publication_url": "https://clinicaltrials.gov/study/NCT05269394",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2021-12-22",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05243797",
"publication_url": "https://clinicaltrials.gov/study/NCT05243797",
"title": "Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4",
"has_exemption": false,
"start_date": "2022-09-08",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "European Myeloma Network B.V.",
"sponsor_slug": "european-myeloma-network-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04922333",
"publication_url": "https://clinicaltrials.gov/study/NCT04922333",
"title": "Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery",
"has_exemption": false,
"start_date": "2023-03-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05681299",
"publication_url": "https://clinicaltrials.gov/study/NCT05681299",
"title": "Effects of Administration of Growth Hormone, Without and With Liraglutide, on AgRP, Energy and Glucose Metabolism in Healthy and GH Deficient Humans",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05840211",
"publication_url": "https://clinicaltrials.gov/study/NCT05840211",
"title": "A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) (HER2 IHC0 or HER2-low [IHC 1+, IHC 2+/ISH-]) Inoperable, Locally Advanced, or Metastatic Breast Cancer and Have Received Endocrine Therapy",
"has_exemption": false,
"start_date": "2023-05-08",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05313243",
"publication_url": "https://clinicaltrials.gov/study/NCT05313243",
"title": "Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma",
"has_exemption": false,
"start_date": "2023-07-10",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05886920",
"publication_url": "https://clinicaltrials.gov/study/NCT05886920",
"title": "A Phase 1/2, Open Label, Dose-escalation, and Dose-expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose of D3S-002 Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations",
"has_exemption": false,
"start_date": "2023-07-10",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "D3 Bio (Wuxi) Co., Ltd",
"sponsor_slug": "d3-bio-wuxi-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05540574",
"publication_url": "https://clinicaltrials.gov/study/NCT05540574",
"title": "Randomized Placebo-Controlled Crossover Trial of Zolpidem for Sleep in Children With Autism",
"has_exemption": false,
"start_date": "2023-08-09",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06020716",
"publication_url": "https://clinicaltrials.gov/study/NCT06020716",
"title": "A Phase 4 Double Blinded Study With Two Different Interventions, Each With Two Arms, to Evaluate the Clinical Efficacy of Antibiotics and the Role of Microbiology, Immunology and Genetics in Children Aged 9-36 Months With Chronic Wet Cough.",
"has_exemption": false,
"start_date": "2023-08-16",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Helse Stavanger HF",
"sponsor_slug": "helse-stavanger-hf",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06007183",
"publication_url": "https://clinicaltrials.gov/study/NCT06007183",
"title": "A Long-term Follow-up Study to Evaluate Safety and Immunogenicity of a Chikungunya Virus Virus-like Particle Vaccine (PXVX0317) in Healthy Adults and Adolescents After Either a Single or Booster Vaccination Dosing Regimen",
"has_exemption": false,
"start_date": "2023-08-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bavarian Nordic",
"sponsor_slug": "bavarian-nordic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06092034",
"publication_url": "https://clinicaltrials.gov/study/NCT06092034",
"title": "Gene Therapy for Danon Disease: A Phase 2 Study Evaluating the Efficacy and Safety of Intravenously Administered Adeno-Associated Virus Serotype 9 (rAAV9) Vector Containing the Human LAMP2 Isoform B Transgene (RP-A501; AAV9.LAMP2B) in Male Patients With Danon Disease",
"has_exemption": false,
"start_date": "2023-09-05",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rocket Pharmaceuticals Inc.",
"sponsor_slug": "rocket-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05980000",
"publication_url": "https://clinicaltrials.gov/study/NCT05980000",
"title": "Open-Label, Randomized Phase 2 Trial of Ramucirumab in Combination With Pembrolizumab Versus Pembrolizumab Alone as First-Line Treatment of PD-L1 Positive, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma (RM-HNSCC)",
"has_exemption": false,
"start_date": "2023-10-27",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06162611",
"publication_url": "https://clinicaltrials.gov/study/NCT06162611",
"title": "Generating Evidence to Improve Same-day Etonogestrel (ENG) Implant Insertion for Emergency Contraception",
"has_exemption": false,
"start_date": "2023-11-06",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Lori Gawron",
"sponsor_slug": "lori-gawron",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05383742",
"publication_url": "https://clinicaltrials.gov/study/NCT05383742",
"title": "A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis: Improved Management With Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)",
"has_exemption": false,
"start_date": "2023-12-07",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06109467",
"publication_url": "https://clinicaltrials.gov/study/NCT06109467",
"title": "A Phase II Study Of Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Overexpressing Gastroesophageal Cancers",
"has_exemption": false,
"start_date": "2024-01-12",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05822362",
"publication_url": "https://clinicaltrials.gov/study/NCT05822362",
"title": "Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial",
"has_exemption": false,
"start_date": "2024-01-19",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06346067",
"publication_url": "https://clinicaltrials.gov/study/NCT06346067",
"title": "A Randomized, Open-label Phase III Study in Patients With Previously Treated Unresectable or Metastatic NRAS Mutant Cutaneous Melanoma Comparing the Combination of Naporafenib + Trametinib to Physician's Choice of Therapy (Dacarbazine, Temozolomide or Trametinib Monotherapy) With a Dose Optimization lead-in [SEACRAFT-2]",
"has_exemption": false,
"start_date": "2024-04-29",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Erasca, Inc.",
"sponsor_slug": "erasca-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05992831",
"publication_url": "https://clinicaltrials.gov/study/NCT05992831",
"title": "Transcranial Magnetic Stimulation for MCI: A Phase II Dose-Response Study",
"has_exemption": false,
"start_date": "2024-06-18",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06411210",
"publication_url": "https://clinicaltrials.gov/study/NCT06411210",
"title": "Obesity Complicating Type 1 Diabetes in Young Adults: Physiology and Impact of GLP-1 Analogue Anti-obesity Treatment on Cardiometabolic Risk Factors",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06547216",
"publication_url": "https://clinicaltrials.gov/study/NCT06547216",
"title": "A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)",
"has_exemption": false,
"start_date": "2024-07-25",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06619990",
"publication_url": "https://clinicaltrials.gov/study/NCT06619990",
"title": "A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis.",
"has_exemption": false,
"start_date": "2024-10-10",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Xencor, Inc.",
"sponsor_slug": "xencor-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06194851",
"publication_url": "https://clinicaltrials.gov/study/NCT06194851",
"title": "A Randomized Clinical Trial Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06724237",
"publication_url": "https://clinicaltrials.gov/study/NCT06724237",
"title": "A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients With Peripheral T Cell Lymphoma That Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eastern Cooperative Oncology Group",
"sponsor_slug": "eastern-cooperative-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712420",
"publication_url": "https://clinicaltrials.gov/study/NCT06712420",
"title": "Neoadjuvant Chemotherapy Versus Upfront Surgery for Locally Advanced Resectable Gall Bladder Cancer : A Randomized Trial",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rajiv Gandhi Cancer Institute & Research Center, India",
"sponsor_slug": "rajiv-gandhi-cancer-institute-research-center-india",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06722755",
"publication_url": "https://clinicaltrials.gov/study/NCT06722755",
"title": "Optimizing Adherence to the Treatment of Sleep Apnea Among Patients With Stroke Undergoing Inpatient Rehabilitation",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06788990",
"publication_url": "https://clinicaltrials.gov/study/NCT06788990",
"title": "A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-01-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bicara Therapeutics",
"sponsor_slug": "bicara-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06767514",
"publication_url": "https://clinicaltrials.gov/study/NCT06767514",
"title": "A Randomized, Double-blinded, Multiregional Phase 3 Study of Ivonescimab Versus Pembrolizumab for the First-line Treatment of Metastatic Non-small Cell Lung Cancer in Patients Whose Tumors Demonstrate High PD-L1 Expression",
"has_exemption": false,
"start_date": "2025-02-27",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Summit Therapeutics",
"sponsor_slug": "summit-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06859268",
"publication_url": "https://clinicaltrials.gov/study/NCT06859268",
"title": "A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Retatrutide Treatment in the Maintenance of Weight Reduction in Individuals With Obesity",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858254",
"publication_url": "https://clinicaltrials.gov/study/NCT06858254",
"title": "Standard Optimization of Autologous Stem Cells by Intranasal and Intravenous Administration to Treat Parkinson's Disease and Atypical Parkinsonism",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apeiron Research Center",
"sponsor_slug": "apeiron-research-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06866275",
"publication_url": "https://clinicaltrials.gov/study/NCT06866275",
"title": "Suramin for the Treatment of Autism Trial (STAT): A Randomized, Double Blind, Crossover Trial of KZ101 in a Male Pediatric Population With Autism Spectrum Disorder",
"has_exemption": false,
"start_date": "2025-04-09",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Orange County",
"sponsor_slug": "childrens-hospital-of-orange-county",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06929286",
"publication_url": "https://clinicaltrials.gov/study/NCT06929286",
"title": "COMparative Prospective Assessment Through Clinically Integrated Randomized Trials Evaluating Intravesical Treatments: The COMPARE IT Trial",
"has_exemption": false,
"start_date": "2025-04-11",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931821",
"publication_url": "https://clinicaltrials.gov/study/NCT06931821",
"title": "Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06899711",
"publication_url": "https://clinicaltrials.gov/study/NCT06899711",
"title": "A Prospective Study to Evaluate the Protective Effects of External Cranial Prosthesis on Incidence of Sunken Flap Syndrome in Decompressive Craniectomy Patients",
"has_exemption": false,
"start_date": "2025-04-26",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06636136",
"publication_url": "https://clinicaltrials.gov/study/NCT06636136",
"title": "Transtibial Osseointegration Surgery Study (TOSS)",
"has_exemption": false,
"start_date": "2025-05-20",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Walter Reed National Military Medical Center",
"sponsor_slug": "walter-reed-national-military-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06957704",
"publication_url": "https://clinicaltrials.gov/study/NCT06957704",
"title": "Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Federal University of São Paulo",
"sponsor_slug": "federal-university-of-sao-paulo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06852365",
"publication_url": "https://clinicaltrials.gov/study/NCT06852365",
"title": "Resistant Starch Usage in Polycystic Ovary Syndrome: Impact on Cardiometabolic Dysfunction and the Gut Microbiome (CORS-PCOS)",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06405607",
"publication_url": "https://clinicaltrials.gov/study/NCT06405607",
"title": "Psilocybin vs Ketamine for Alcohol Use Disorder",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Iowa",
"sponsor_slug": "university-of-iowa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937086",
"publication_url": "https://clinicaltrials.gov/study/NCT06937086",
"title": "A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228078",
"publication_url": "https://clinicaltrials.gov/study/NCT07228078",
"title": "An Open-Label Extension (OLE) Study to Evaluate the Long-Term Safety, Tolerability and Exploratory Efficacy of SNK01 in Participants With Alzheimer's Disease (Study SNK01-AD02)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NKGen Biotech, Inc.",
"sponsor_slug": "nkgen-biotech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06981078",
"publication_url": "https://clinicaltrials.gov/study/NCT06981078",
"title": "A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Assess Efficacy and Safety of Verekitug (UPB-101) in Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)",
"has_exemption": false,
"start_date": "2025-07-02",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Upstream Bio Inc.",
"sponsor_slug": "upstream-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06556693",
"publication_url": "https://clinicaltrials.gov/study/NCT06556693",
"title": "Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy",
"has_exemption": false,
"start_date": "2025-08-12",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Zoll Medical Corporation",
"sponsor_slug": "zoll-medical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06982521",
"publication_url": "https://clinicaltrials.gov/study/NCT06982521",
"title": "A Phase 3 Open-Label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment With a CDK4/6 Inhibitor",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Relay Therapeutics, Inc.",
"sponsor_slug": "relay-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07011719",
"publication_url": "https://clinicaltrials.gov/study/NCT07011719",
"title": "A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-09-08",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arcus Biosciences, Inc.",
"sponsor_slug": "arcus-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07153471",
"publication_url": "https://clinicaltrials.gov/study/NCT07153471",
"title": "A Phase 3 Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06835400",
"publication_url": "https://clinicaltrials.gov/study/NCT06835400",
"title": "An Open-Label, Randomized, Two-stage Study to Determine Dose Optimization, Safety, and Noninferiority of Oral Paclitaxel + Encequidar Compared to IV Paclitaxel in Subjects With HER2 Negative Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Health Hope Pharma",
"sponsor_slug": "health-hope-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06848140",
"publication_url": "https://clinicaltrials.gov/study/NCT06848140",
"title": "Using High Definition Transcranial Direct Current Stimulation to Treat Verbal Retrieval Deficits Secondary to Chronic Traumatic Brain Injury (STIM-CTBI)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06858787",
"publication_url": "https://clinicaltrials.gov/study/NCT06858787",
"title": "The Validity of a Continuous Glucose Monitor in Diagnosing Gestational Diabetes: A Pilot Study",
"has_exemption": false,
"start_date": "2025-10-02",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219966",
"publication_url": "https://clinicaltrials.gov/study/NCT07219966",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1)",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219953",
"publication_url": "https://clinicaltrials.gov/study/NCT07219953",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Alcohol Use Disorder (RENEW-ALC-2)",
"has_exemption": false,
"start_date": "2025-10-16",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07219173",
"publication_url": "https://clinicaltrials.gov/study/NCT07219173",
"title": "A Phase 2, Multicenter, Randomized, Double-blind, 52-week Study, to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Uncontrolled Moderate to Severe Asthma",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07213804",
"publication_url": "https://clinicaltrials.gov/study/NCT07213804",
"title": "FRAmework-01: A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) Versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan Plus Bevacizumab Versus Platinum-Based Chemotherapy Plus Bevacizumab in Platinum-Sensitive Ovarian Cancer.",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06734039",
"publication_url": "https://clinicaltrials.gov/study/NCT06734039",
"title": "Impact of Anatomy-Based Frequency (ABF) Allocations on Early Performance Outcomes in MED-EL Cochlear Implant Recipients",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Med-El Corporation",
"sponsor_slug": "med-el-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07089576",
"publication_url": "https://clinicaltrials.gov/study/NCT07089576",
"title": "A Prospective, Multi-center Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA in the Open Repair of Aortic Arch Aneurysms and Dissections",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Artivion Inc.",
"sponsor_slug": "artivion-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07236606",
"publication_url": "https://clinicaltrials.gov/study/NCT07236606",
"title": "A Phase 3, Open-Label Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of RGX 121 in Pediatric Participants With Neuronopathic MPS II (Hunter Syndrome)",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regenxbio Inc.",
"sponsor_slug": "regenxbio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07244705",
"publication_url": "https://clinicaltrials.gov/study/NCT07244705",
"title": "An Open-label, Multicenter, Phase 1/2 Study Exploring the Safety and Efficacy of ABT-301 in Combination With Tislelizumab and Bevacizumab in Participants With Proficient Mismatch Repair (pMMR)/Non-Microsatellite Instability-High (Non-MSI-H) Locally Advanced or Metastatic Colorectal Cancer (mCRC)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Anbogen Therapeutics, Inc.",
"sponsor_slug": "anbogen-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07125235",
"publication_url": "https://clinicaltrials.gov/study/NCT07125235",
"title": "Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) mHealth Randomized Controlled Hybrid Type I Effectiveness Implementation Trial",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06258525",
"publication_url": "https://clinicaltrials.gov/study/NCT06258525",
"title": "A Phase II, Open-Label Trial of S-Adenosylmethionine (SAMe) in Prevention of Oxaliplatin Associated Liver Injury",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224022",
"publication_url": "https://clinicaltrials.gov/study/NCT07224022",
"title": "NACho: A Phase II Study of Neo-Adjuvant Cemiplimab With Fianlimab for Resectable Non-Metastatic Colon Cancer",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "John Strickler, M.D.",
"sponsor_slug": "john-strickler-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07234968",
"publication_url": "https://clinicaltrials.gov/study/NCT07234968",
"title": "Randomized Controlled Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226453",
"publication_url": "https://clinicaltrials.gov/study/NCT07226453",
"title": "A Target Validation and Efficacy Study of Metformin in Patients With Recurrent or Progressive Posterior Fossa Group A (PFA) Ependymoma",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116460",
"publication_url": "https://clinicaltrials.gov/study/NCT07116460",
"title": "Cost Effective Air Filtration Intervention and Particulate Matter Monitoring in Low-Income Housing to Reduce Asthma Morbidity",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03567824",
"publication_url": "https://clinicaltrials.gov/study/NCT03567824",
"title": "A Phase 2 Open Label Study of Magnesium L-Lactate Dihydrate (MLD10) 10 mEq Extended-Release Caplets Administered BID for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus Followed by a Blinded Random Off Phase",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharmalyte Solutions LLC",
"sponsor_slug": "pharmalyte-solutions-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06615752",
"publication_url": "https://clinicaltrials.gov/study/NCT06615752",
"title": "A Phase I/II Study to Determine the Safety and Efficacy of a Combination of Green Tea and Quercetin With Docetaxel in Castration-resistant Prostate Cancer Patients",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Charles Drew University of Medicine and Science",
"sponsor_slug": "charles-drew-university-of-medicine-and-science",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06743113",
"publication_url": "https://clinicaltrials.gov/study/NCT06743113",
"title": "A Multi-Center, Randomized, Controlled, Cross-Over Study to Evaluate the Effectiveness of Hypoxic Red Blood Cells Processed With the Hemanext ONE® System Versus Conventional Red Blood Cells in Patients With Transfusion Dependent Sickle Cell Anemia",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hemanext",
"sponsor_slug": "hemanext",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05855694",
"publication_url": "https://clinicaltrials.gov/study/NCT05855694",
"title": "Pilot Study of Photobiomodulation for Cancer-Related Cognitive Impairment",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arash Asher, MD",
"sponsor_slug": "arash-asher-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07306078",
"publication_url": "https://clinicaltrials.gov/study/NCT07306078",
"title": "Attentional Ability and Resilience to Alcohol Use Disorder: Neurocognitive Mechanisms: Protocol Two",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04860635",
"publication_url": "https://clinicaltrials.gov/study/NCT04860635",
"title": "An Open Label Safety Study of a Single Administration of F14 in Patients Undergoing Unilateral Total Knee Replacement",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Arthritis Innovation Corporation",
"sponsor_slug": "arthritis-innovation-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06320951",
"publication_url": "https://clinicaltrials.gov/study/NCT06320951",
"title": "Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2028-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04214262",
"publication_url": "https://clinicaltrials.gov/study/NCT04214262",
"title": "A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC",
"has_exemption": false,
"start_date": "2020-08-13",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04906408",
"publication_url": "https://clinicaltrials.gov/study/NCT04906408",
"title": "The Effects of Post-Operative Interventions on Surgical Site Occurrences in Abdominal Wall Reconstructions: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2021-09-17",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05764395",
"publication_url": "https://clinicaltrials.gov/study/NCT05764395",
"title": "A Phase II Study to Evaluate the Safety and Efficacy of Rigosertib (ON 01910) Plus Pembrolizumab in Patients With Metastatic Melanoma Refractory to Immune Checkpoint Blockade",
"has_exemption": false,
"start_date": "2023-05-09",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt-Ingram Cancer Center",
"sponsor_slug": "vanderbilt-ingram-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05899153",
"publication_url": "https://clinicaltrials.gov/study/NCT05899153",
"title": "Quantifying Patient-specific Changes in Neuromuscular Control in Cerebral Palsy: Adaptation and Biofeedback During Gait",
"has_exemption": false,
"start_date": "2023-11-28",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06029309",
"publication_url": "https://clinicaltrials.gov/study/NCT06029309",
"title": "A Phase 1/2 Study of Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-05-03",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Alvaro Alencar, MD",
"sponsor_slug": "alvaro-alencar-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06706284",
"publication_url": "https://clinicaltrials.gov/study/NCT06706284",
"title": "Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2025-04-11",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Marzieh Salehi",
"sponsor_slug": "marzieh-salehi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06831058",
"publication_url": "https://clinicaltrials.gov/study/NCT06831058",
"title": "A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06499285",
"publication_url": "https://clinicaltrials.gov/study/NCT06499285",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept (KER-050) for the Treatment of Transfusion-Dependent Anemia in Adult Participants With Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) (RENEW)",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06930651",
"publication_url": "https://clinicaltrials.gov/study/NCT06930651",
"title": "A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07172841",
"publication_url": "https://clinicaltrials.gov/study/NCT07172841",
"title": "Randomized Controlled Study on Non-invasive Diagnostics of Shunt Obstruction in Adult Hydrocephalus",
"has_exemption": false,
"start_date": "2025-09-15",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Göteborg University",
"sponsor_slug": "goteborg-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209371",
"publication_url": "https://clinicaltrials.gov/study/NCT07209371",
"title": "Rifaximin Versus No Intervention in Patients With IgA Monoclonal Gammopathy of Undetermined Significance",
"has_exemption": false,
"start_date": "2026-01-22",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Fred Hutchinson Cancer Center",
"sponsor_slug": "fred-hutchinson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07283900",
"publication_url": "https://clinicaltrials.gov/study/NCT07283900",
"title": "Title: A Phase II Trial of High Dose Ascorbate in Combination With Azacitidine in Adults With Myelodysplastic Syndrome",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Prajwal Dhakal",
"sponsor_slug": "prajwal-dhakal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06193317",
"publication_url": "https://clinicaltrials.gov/study/NCT06193317",
"title": "Effects of taVNS on Fibromyalgia Pain",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Spaulding Rehabilitation Hospital",
"sponsor_slug": "spaulding-rehabilitation-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05710887",
"publication_url": "https://clinicaltrials.gov/study/NCT05710887",
"title": "Inhaled Nitrous Oxide for Acute Suicidality and Depression in the Emergency Department",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2028-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03701282",
"publication_url": "https://clinicaltrials.gov/study/NCT03701282",
"title": "A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)",
"has_exemption": false,
"start_date": "2019-02-12",
"completion_date": "2028-05-07",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05892068",
"publication_url": "https://clinicaltrials.gov/study/NCT05892068",
"title": "Window of Opportunity Analysis of Pre-Operative Tucatinib for Surgically Resected HER2+ Brain Metastases: Understanding Mechanisms of Resistance",
"has_exemption": false,
"start_date": "2023-05-09",
"completion_date": "2028-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07184996",
"publication_url": "https://clinicaltrials.gov/study/NCT07184996",
"title": "A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis.",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2028-05-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05874635",
"publication_url": "https://clinicaltrials.gov/study/NCT05874635",
"title": "Use of Signos mHealth Platform in Participants With Non-Insulin Dependent Type 2 Diabetes: Weight and Blood Glucose",
"has_exemption": false,
"start_date": "2023-05-11",
"completion_date": "2028-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Signos Inc",
"sponsor_slug": "signos-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06136650",
"publication_url": "https://clinicaltrials.gov/study/NCT06136650",
"title": "MK-5684-004: A Phase 3, Randomized, Open-label Study of Opevesostat Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment With One Next-generation Hormonal Agent (NHA) (OMAHA-004)",
"has_exemption": false,
"start_date": "2023-12-18",
"completion_date": "2028-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06414863",
"publication_url": "https://clinicaltrials.gov/study/NCT06414863",
"title": "Treatment Effects of Invisalign Palatal Expander System and Hyrax Palatal Expander - A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-05-10",
"completion_date": "2028-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "University of the Pacific",
"sponsor_slug": "university-of-the-pacific",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04064060",
"publication_url": "https://clinicaltrials.gov/study/NCT04064060",
"title": "A Phase 3b, Open-label, Single-arm, Rollover Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials",
"has_exemption": false,
"start_date": "2019-08-12",
"completion_date": "2028-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06984523",
"publication_url": "https://clinicaltrials.gov/study/NCT06984523",
"title": "A Phase II Single-Arm Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis",
"has_exemption": false,
"start_date": "2025-05-14",
"completion_date": "2028-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07296055",
"publication_url": "https://clinicaltrials.gov/study/NCT07296055",
"title": "Evaluating the Utility of Endobronchial Valves in the Management of Tubercular and NTM (Non Tubercolar Micobacteriosis) Pulmonary Cavities",
"has_exemption": false,
"start_date": "2026-01-12",
"completion_date": "2028-05-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Azienda Ospedaliero-Universitaria Careggi",
"sponsor_slug": "azienda-ospedaliero-universitaria-careggi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07142252",
"publication_url": "https://clinicaltrials.gov/study/NCT07142252",
"title": "Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus",
"has_exemption": false,
"start_date": "2025-11-13",
"completion_date": "2028-05-13",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07210086",
"publication_url": "https://clinicaltrials.gov/study/NCT07210086",
"title": "Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)",
"has_exemption": false,
"start_date": "2025-12-11",
"completion_date": "2028-05-13",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05650359",
"publication_url": "https://clinicaltrials.gov/study/NCT05650359",
"title": "A Randomized and Controlled Study of the Use of Orthopulse Photobiomodulation for Acceleration of Orthodontic Tooth Movement With Fixed Appliances",
"has_exemption": false,
"start_date": "2022-10-13",
"completion_date": "2028-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Biolux Technology GmbH",
"sponsor_slug": "biolux-technology-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06846671",
"publication_url": "https://clinicaltrials.gov/study/NCT06846671",
"title": "A Phase 3, Open-Label, Randomized Study of BGB-16673 Compared to Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab or Venetoclax Plus Rituximab Retreatment) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both BTK and BCL2 Inhibitors",
"has_exemption": false,
"start_date": "2025-04-10",
"completion_date": "2028-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06954987",
"publication_url": "https://clinicaltrials.gov/study/NCT06954987",
"title": "A Two Cohort, Randomized, Double-Blind, Placebo-Controlled, Phase II Multi-Center Signal-Finding Study of Venetoclax Combined With Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation Then Venetoclax Maintenance in Adult Patients With Acute Myeloid Leukemia in First Complete Remission: A MyeloMATCH Sub-Study",
"has_exemption": false,
"start_date": "2026-03-18",
"completion_date": "2028-05-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05608291",
"publication_url": "https://clinicaltrials.gov/study/NCT05608291",
"title": "A Phase 3 Trial of Fianlimab (Anti-LAG-3) and Cemiplimab Versus Pembrolizumab in the Adjuvant Setting in Patients With Completely Resected High-risk Melanoma",
"has_exemption": false,
"start_date": "2023-01-16",
"completion_date": "2028-05-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015983",
"publication_url": "https://clinicaltrials.gov/study/NCT07015983",
"title": "A Phase 2, Multicenter, Open-Label Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Participants With Active SLE (Including Lupus Nephritis) With Inadequate Response to Glucocorticoids and at Least 2 Immunosuppressants",
"has_exemption": false,
"start_date": "2025-07-14",
"completion_date": "2028-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Juno Therapeutics, Inc., a Bristol-Myers Squibb Company",
"sponsor_slug": "juno-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07357727",
"publication_url": "https://clinicaltrials.gov/study/NCT07357727",
"title": "A Phase 3, Randomized, Double-blind, Active-control Study of Pelabresib (DAK539) and Ruxolitinib vs. Placebo and Ruxolitinib in Adult Patients With Myelofibrosis Who Are JAK Inhibitor Naive",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2028-05-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06463587",
"publication_url": "https://clinicaltrials.gov/study/NCT06463587",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm, 3-Period Study to Assess the Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)",
"has_exemption": false,
"start_date": "2024-06-25",
"completion_date": "2028-05-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany",
"sponsor_slug": "merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-germany",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220785",
"publication_url": "https://clinicaltrials.gov/study/NCT07220785",
"title": "A Two-Part, Randomized, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Pharmacokinetics of Mibavademab in Patients With Generalized Lipodystrophy",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2028-05-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07044726",
"publication_url": "https://clinicaltrials.gov/study/NCT07044726",
"title": "Betadine vs Sterile Water for Periurethral Preparation Prior to Straight Catherization in the Clinic Setting: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-06-23",
"completion_date": "2028-05-21",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05884333",
"publication_url": "https://clinicaltrials.gov/study/NCT05884333",
"title": "Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults",
"has_exemption": false,
"start_date": "2023-05-22",
"completion_date": "2028-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06260163",
"publication_url": "https://clinicaltrials.gov/study/NCT06260163",
"title": "A Phase 3 Randomized, Open-label Induction, Double-blind Maintenance, Parallel-group, Multicenter Protocol to Evaluate the Efficacy, Safety, and Pharmacokinetics of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2024-01-19",
"completion_date": "2028-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06424288",
"publication_url": "https://clinicaltrials.gov/study/NCT06424288",
"title": "EASi-HF Preserved - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) ≥40%",
"has_exemption": false,
"start_date": "2024-06-17",
"completion_date": "2028-05-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03581136",
"publication_url": "https://clinicaltrials.gov/study/NCT03581136",
"title": "Phase II Multi-center Trial Evaluating 5 Fraction S-PBI (Stereotactic Partial Breast Irradiation) for Early Stage Breast Cancer Using the GammaPod",
"has_exemption": false,
"start_date": "2019-04-22",
"completion_date": "2028-05-25",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07047690",
"publication_url": "https://clinicaltrials.gov/study/NCT07047690",
"title": "A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of Nemolizumab in Adult Patients With Systemic Sclerosis",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2028-05-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Galderma R&D",
"sponsor_slug": "galderma-rd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06685068",
"publication_url": "https://clinicaltrials.gov/study/NCT06685068",
"title": "A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-11-13",
"completion_date": "2028-05-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06012695",
"publication_url": "https://clinicaltrials.gov/study/NCT06012695",
"title": "A Phase Ib/II, Open-label Study of NBM-BMX As Monotherapy or in Combination with Radiotherapy and Temozolomide in Subjects with Solid Tumors or Newly Diagnosed Glioblastoma",
"has_exemption": false,
"start_date": "2023-08-11",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novelwise Pharmaceutical Corporation",
"sponsor_slug": "novelwise-pharmaceutical-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986993",
"publication_url": "https://clinicaltrials.gov/study/NCT06986993",
"title": "Impact of Semaglutide Administration on Tobacco Use Behavior and Related Mechanisms Among Smokers With Obesity",
"has_exemption": false,
"start_date": "2024-07-01",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Oklahoma",
"sponsor_slug": "university-of-oklahoma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05866562",
"publication_url": "https://clinicaltrials.gov/study/NCT05866562",
"title": "Dupilumab in the Treatment of Pediatric Alopecia Areata",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06266611",
"publication_url": "https://clinicaltrials.gov/study/NCT06266611",
"title": "Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC",
"has_exemption": false,
"start_date": "2024-09-16",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Boulder",
"sponsor_slug": "university-of-colorado-boulder",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679946",
"publication_url": "https://clinicaltrials.gov/study/NCT06679946",
"title": "An Open-Label Extension Study to Assess the Safety and Efficacy of Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)",
"has_exemption": false,
"start_date": "2024-12-03",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Alnylam Pharmaceuticals",
"sponsor_slug": "alnylam-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06949228",
"publication_url": "https://clinicaltrials.gov/study/NCT06949228",
"title": "Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ProMedica Health System",
"sponsor_slug": "promedica-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07164443",
"publication_url": "https://clinicaltrials.gov/study/NCT07164443",
"title": "A Phase 3 Randomized, Double-blind, Placebo-controlled Study of Pasritamig (JNJ-78278343), a T Cell Redirecting Agent Targeting Human Kallikrein 2, + Best Supportive Care Versus Best Supportive Care for Metastatic Castration-resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2025-09-02",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918977",
"publication_url": "https://clinicaltrials.gov/study/NCT06918977",
"title": "Evaluation of a Novel Telemedicine Clinic for Patients With DM2 on Multiple Daily Insulin (MDI) Regimens",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218926",
"publication_url": "https://clinicaltrials.gov/study/NCT07218926",
"title": "A Phase 3, Randomized, Multicenter, Open-Label Study of IDRX-42 (GSK6042981) Versus Sunitinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) After Imatinib Therapy (StrateGIST 3)",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282574",
"publication_url": "https://clinicaltrials.gov/study/NCT07282574",
"title": "A Multi-center, Double-blind, Placebo-controlled, Phase II Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489, a Monoacylglycerol Lipase Inhibitor, as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07224711",
"publication_url": "https://clinicaltrials.gov/study/NCT07224711",
"title": "The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Abdominal Surgery (IMPALA ERAS)",
"has_exemption": false,
"start_date": "2026-06-01",
"completion_date": "2028-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanderbilt University Medical Center",
"sponsor_slug": "vanderbilt-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03047746",
"publication_url": "https://clinicaltrials.gov/study/NCT03047746",
"title": "Unrelated And Partially Matched Related Donor Peripheral Blood Stem Cell Transplantation (PSCT) With TCR αβ + T Cell And B Cell Depletion For Patients With Acquired And Inherited Bone Marrow Failure",
"has_exemption": false,
"start_date": "2017-02-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03422302",
"publication_url": "https://clinicaltrials.gov/study/NCT03422302",
"title": "Measuring the Effectiveness of a Continuous Positive Airway Pressure (CPAP) Device to Reduce Tumor Motion and Increase Lung Volume Expansion in Patients Undergoing Stereotactic Body Radiotherapy (SBRT) for Tumors That Move With Respiration",
"has_exemption": false,
"start_date": "2018-03-16",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03417297",
"publication_url": "https://clinicaltrials.gov/study/NCT03417297",
"title": "A Pilot Open-label Clinical Trial Evaluating the ExAblate Model 4000 Type-1 Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy",
"has_exemption": false,
"start_date": "2018-04-24",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04471974",
"publication_url": "https://clinicaltrials.gov/study/NCT04471974",
"title": "A Phase 2 Study of BET Bromodomain Inhibitor ZEN-3694 in Combination With Enzalutamide Plus Pembrolizumab in Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2021-01-26",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rahul Aggarwal",
"sponsor_slug": "rahul-aggarwal",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04411654",
"publication_url": "https://clinicaltrials.gov/study/NCT04411654",
"title": "An Open-label, Phase 1/2 Study to Evaluate the Safety and Efficacy of Single-dose LY3884961 in Infants With Type 2 Gaucher Disease",
"has_exemption": false,
"start_date": "2021-06-29",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prevail Therapeutics",
"sponsor_slug": "prevail-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03742414",
"publication_url": "https://clinicaltrials.gov/study/NCT03742414",
"title": "SEAL (Stopping Eczema and ALlergy) Study: Prevent the Allergic March by Enhancing the Skin Barrier",
"has_exemption": false,
"start_date": "2021-06-30",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kari Nadeau, MD, PhD",
"sponsor_slug": "kari-nadeau-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05083481",
"publication_url": "https://clinicaltrials.gov/study/NCT05083481",
"title": "A Phase 1/2 Study of ASP1570 as Monotherapy and in Combination With Pembrolizumab and/or Standard Therapies Including Chemotherapy and/or Immunotherapy in Participants With Locally Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2021-10-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05045950",
"publication_url": "https://clinicaltrials.gov/study/NCT05045950",
"title": "Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique (ONCO-RT) - A Phase II Trial of Upfront Pulsed Reduced Dose Rate Whole-Brain Radiation Therapy for Brain Metastases",
"has_exemption": false,
"start_date": "2021-11-17",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06284473",
"publication_url": "https://clinicaltrials.gov/study/NCT06284473",
"title": "Intranasal Ketamine as a Supplement to Local Anesthesia to Reduce Pain Associated With Minor Procedures in the Emergency Department",
"has_exemption": false,
"start_date": "2022-05-25",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Loyola University",
"sponsor_slug": "loyola-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05047172",
"publication_url": "https://clinicaltrials.gov/study/NCT05047172",
"title": "Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)",
"has_exemption": false,
"start_date": "2022-08-02",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05508789",
"publication_url": "https://clinicaltrials.gov/study/NCT05508789",
"title": "Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease",
"has_exemption": false,
"start_date": "2022-10-10",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05528133",
"publication_url": "https://clinicaltrials.gov/study/NCT05528133",
"title": "Phase II Study of Genomically Guided Radiation Dose Personalization in the Management of Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2023-01-25",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05896293",
"publication_url": "https://clinicaltrials.gov/study/NCT05896293",
"title": "Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders",
"has_exemption": false,
"start_date": "2023-02-03",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephanie B. Seminara, MD",
"sponsor_slug": "stephanie-b-seminara-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04796792",
"publication_url": "https://clinicaltrials.gov/study/NCT04796792",
"title": "Ultrasound Technology to Fragment and Reposition Urinary Stones",
"has_exemption": false,
"start_date": "2023-04-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05737199",
"publication_url": "https://clinicaltrials.gov/study/NCT05737199",
"title": "A Single-arm Open-label Phase II Trial to Assess the Efficacy and Safety of Pembrolizumab for Unresectable Advanced or Recurrent Ovarian Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Niigata University Medical & Dental Hospital",
"sponsor_slug": "niigata-university-medical-dental-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05866536",
"publication_url": "https://clinicaltrials.gov/study/NCT05866536",
"title": "Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years",
"has_exemption": false,
"start_date": "2023-05-04",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05943210",
"publication_url": "https://clinicaltrials.gov/study/NCT05943210",
"title": "The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer.",
"has_exemption": false,
"start_date": "2023-05-22",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05805839",
"publication_url": "https://clinicaltrials.gov/study/NCT05805839",
"title": "Advanced MR and PET Imaging in Inflammatory Demyelinating Diseases of the Central Nervous System",
"has_exemption": false,
"start_date": "2023-07-10",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06023589",
"publication_url": "https://clinicaltrials.gov/study/NCT06023589",
"title": "A Multicentre, Randomised, Double-Blind, Parallel-Group Placebo-Controlled, Phase 3, Efficacy and Safety Study of Tezepelumab in 5 to < 12 Year Old Children With Severe Uncontrolled Asthma (HORIZON)",
"has_exemption": false,
"start_date": "2023-08-24",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05948943",
"publication_url": "https://clinicaltrials.gov/study/NCT05948943",
"title": "A Two-stage Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.",
"has_exemption": false,
"start_date": "2023-11-24",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06003348",
"publication_url": "https://clinicaltrials.gov/study/NCT06003348",
"title": "Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones",
"has_exemption": false,
"start_date": "2023-12-13",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305039",
"publication_url": "https://clinicaltrials.gov/study/NCT06305039",
"title": "Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments - Part 2",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, College Park",
"sponsor_slug": "university-of-maryland-college-park",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06094192",
"publication_url": "https://clinicaltrials.gov/study/NCT06094192",
"title": "Personalized Synchronization of Cortical Rhythms to Improve Memory in Alzheimer's Disease",
"has_exemption": false,
"start_date": "2023-12-20",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston University Charles River Campus",
"sponsor_slug": "boston-university-charles-river-campus",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06347978",
"publication_url": "https://clinicaltrials.gov/study/NCT06347978",
"title": "A Double-Blinded, Randomized, Crossover Trial of Stereoencephalography- Guided Four-Lead Personalized Deep Brain Stimulation for Treatment-Refractory Obsessive Compulsive Disorder (SEEG-Guided DBS for OCD)",
"has_exemption": false,
"start_date": "2024-05-24",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Andrew Moses Lee, MD, PhD",
"sponsor_slug": "andrew-moses-lee-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264882",
"publication_url": "https://clinicaltrials.gov/study/NCT06264882",
"title": "Cardiometabolic Consequences of the Loss of Ovarian Function",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06205836",
"publication_url": "https://clinicaltrials.gov/study/NCT06205836",
"title": "Evaluating a Surgical-Sparing Approach Using Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer",
"has_exemption": false,
"start_date": "2024-06-13",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05932199",
"publication_url": "https://clinicaltrials.gov/study/NCT05932199",
"title": "Combination of Induction Durvalumab and Tremelimumab Alone Versus Durvalumab and Tremelimumab With Chemotherapy for Potentially Resectable Pleural Mesothelioma",
"has_exemption": false,
"start_date": "2024-07-03",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor College of Medicine",
"sponsor_slug": "baylor-college-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05662462",
"publication_url": "https://clinicaltrials.gov/study/NCT05662462",
"title": "ACHIEVE: Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ohio State University",
"sponsor_slug": "ohio-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961487",
"publication_url": "https://clinicaltrials.gov/study/NCT06961487",
"title": "Endovascular Therapy for Large Core Patients With Uncertain Response to Thrombectomy (OUTER LIMITS)",
"has_exemption": false,
"start_date": "2024-07-26",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06475742",
"publication_url": "https://clinicaltrials.gov/study/NCT06475742",
"title": "A Phase 3, Multicenter, Open-label, Single-arm, Extension Study to Evaluate the Long-term Safety and Tolerability of Cenerimod in Adult Subjects With Moderate-to-Severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy",
"has_exemption": false,
"start_date": "2024-07-30",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Viatris Innovation GmbH",
"sponsor_slug": "viatris-innovation-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06031688",
"publication_url": "https://clinicaltrials.gov/study/NCT06031688",
"title": "A Randomized Phase II Study of Tepotinib With or Without Ramucirumab in Participants With MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)",
"has_exemption": false,
"start_date": "2024-08-08",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06320366",
"publication_url": "https://clinicaltrials.gov/study/NCT06320366",
"title": "Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06334315",
"publication_url": "https://clinicaltrials.gov/study/NCT06334315",
"title": "Influence of Genetics Variants on the Pharmacokinetics and Pharmacodynamics of Combined Oral Contraceptive Pill Users",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06481592",
"publication_url": "https://clinicaltrials.gov/study/NCT06481592",
"title": "A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Endometrial Cancer.",
"has_exemption": false,
"start_date": "2024-10-29",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Iovance Biotherapeutics, Inc.",
"sponsor_slug": "iovance-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06116682",
"publication_url": "https://clinicaltrials.gov/study/NCT06116682",
"title": "A Phase II Study of Amivantamab SC (Subcutaneous) in Participants With MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (LUNG-MAP SUB-STUDY)",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06617325",
"publication_url": "https://clinicaltrials.gov/study/NCT06617325",
"title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06674577",
"publication_url": "https://clinicaltrials.gov/study/NCT06674577",
"title": "A Multicenter, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept",
"has_exemption": false,
"start_date": "2024-12-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Vera Therapeutics, Inc.",
"sponsor_slug": "vera-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06630234",
"publication_url": "https://clinicaltrials.gov/study/NCT06630234",
"title": "A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)",
"has_exemption": false,
"start_date": "2024-12-10",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Deciphera Pharmaceuticals LLC",
"sponsor_slug": "deciphera-pharmaceuticals-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06533748",
"publication_url": "https://clinicaltrials.gov/study/NCT06533748",
"title": "SJALL23H: Combination Antigen-Directed Induction Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06857942",
"publication_url": "https://clinicaltrials.gov/study/NCT06857942",
"title": "A Phase 4, Prospective, Open-Label, Single Arm Study to Assess the Effectiveness of Tirzepatide After Initiation of Ixekizumab in Adult Participants With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight in Clinical Practice",
"has_exemption": false,
"start_date": "2025-03-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06827236",
"publication_url": "https://clinicaltrials.gov/study/NCT06827236",
"title": "A Phase I/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of BNT323 in Combination With BNT327 in Participants With Advanced Breast Cancer",
"has_exemption": false,
"start_date": "2025-04-23",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976853",
"publication_url": "https://clinicaltrials.gov/study/NCT06976853",
"title": "Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06984861",
"publication_url": "https://clinicaltrials.gov/study/NCT06984861",
"title": "Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Advanced Stage Human Papilloma Virus Associated Oropharyngeal Carcinoma",
"has_exemption": false,
"start_date": "2025-05-13",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986083",
"publication_url": "https://clinicaltrials.gov/study/NCT06986083",
"title": "A Randomized Controlled Trial of Modifications to Prostate Needle-Based Procedures",
"has_exemption": false,
"start_date": "2025-05-19",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06925152",
"publication_url": "https://clinicaltrials.gov/study/NCT06925152",
"title": "COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block",
"has_exemption": false,
"start_date": "2025-05-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Tennessee",
"sponsor_slug": "university-of-tennessee",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06821542",
"publication_url": "https://clinicaltrials.gov/study/NCT06821542",
"title": "A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07038200",
"publication_url": "https://clinicaltrials.gov/study/NCT07038200",
"title": "A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)",
"has_exemption": false,
"start_date": "2025-06-10",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Avidity Biosciences, Inc.",
"sponsor_slug": "avidity-biosciences-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06937099",
"publication_url": "https://clinicaltrials.gov/study/NCT06937099",
"title": "A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight",
"has_exemption": false,
"start_date": "2025-06-26",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06911632",
"publication_url": "https://clinicaltrials.gov/study/NCT06911632",
"title": "MOMENTOUS Study (iMpact Of an Ecg ai ModEl oN The Diagnosis Of pUlmonary hypertenSion)",
"has_exemption": false,
"start_date": "2025-07-23",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tempus AI",
"sponsor_slug": "tempus-ai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06853184",
"publication_url": "https://clinicaltrials.gov/study/NCT06853184",
"title": "Phase 2, Randomized, Open-label, Active Comparator, Dose-ranging Study Evaluating the Efficacy and Safety of Artesunate for Injection in Combination With Ganciclovir or Valganciclovir for the Treatment of Cytomegalovirus Infection in Solid Organ Transplant Recipients",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amivas Inc.",
"sponsor_slug": "amivas-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07133308",
"publication_url": "https://clinicaltrials.gov/study/NCT07133308",
"title": "A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescent Patients With Severe Alopecia Areata With an Open-label Extension Period",
"has_exemption": false,
"start_date": "2025-08-05",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Pharmaceutical Industries, Inc.",
"sponsor_slug": "sun-pharmaceutical-industries-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07020312",
"publication_url": "https://clinicaltrials.gov/study/NCT07020312",
"title": "Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery: A Blinded Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-08-14",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07086976",
"publication_url": "https://clinicaltrials.gov/study/NCT07086976",
"title": "A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Period and Long-term Extension to Assess the Efficacy and Safety of Rilzabrutinib in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07131787",
"publication_url": "https://clinicaltrials.gov/study/NCT07131787",
"title": "Optimizing Rehabilitation After Achilles Tendon Rupture Repair: The Role of Blood Flow Restriction Training in Tendon and Muscle Recovery",
"has_exemption": false,
"start_date": "2025-08-20",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Ghent",
"sponsor_slug": "university-hospital-ghent",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06624475",
"publication_url": "https://clinicaltrials.gov/study/NCT06624475",
"title": "Randomized Phase II Trial Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07053059",
"publication_url": "https://clinicaltrials.gov/study/NCT07053059",
"title": "Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287163",
"publication_url": "https://clinicaltrials.gov/study/NCT07287163",
"title": "Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy",
"has_exemption": false,
"start_date": "2025-10-27",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Praxis Precision Medicines",
"sponsor_slug": "praxis-precision-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07198451",
"publication_url": "https://clinicaltrials.gov/study/NCT07198451",
"title": "Efficacy Evaluation of Submucosal Injection of Gemcitabine in Preventing Recurrence of Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized, Single-Blind, Multicenter Clinical Study",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai University of Traditional Chinese Medicine",
"sponsor_slug": "shanghai-university-of-traditional-chinese-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076212",
"publication_url": "https://clinicaltrials.gov/study/NCT07076212",
"title": "Phase II Study Evaluating NALIRIFOX Versus Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-11-07",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07228832",
"publication_url": "https://clinicaltrials.gov/study/NCT07228832",
"title": "A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination With FOLFOX Versus Bevacizumab in Combination With FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Summit Therapeutics",
"sponsor_slug": "summit-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06979492",
"publication_url": "https://clinicaltrials.gov/study/NCT06979492",
"title": "Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284459",
"publication_url": "https://clinicaltrials.gov/study/NCT07284459",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Oral PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Contineum Therapeutics",
"sponsor_slug": "contineum-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07353957",
"publication_url": "https://clinicaltrials.gov/study/NCT07353957",
"title": "A Phase 2 Study to Investigate the Safety and Efficacy of Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer in Combination With Pembrolizumab as First-Line Treatment",
"has_exemption": false,
"start_date": "2025-12-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merus N.V.",
"sponsor_slug": "merus-nv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308925",
"publication_url": "https://clinicaltrials.gov/study/NCT07308925",
"title": "Effectiveness of Using Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.",
"has_exemption": false,
"start_date": "2026-01-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hospital Universitario San Ignacio",
"sponsor_slug": "hospital-universitario-san-ignacio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325500",
"publication_url": "https://clinicaltrials.gov/study/NCT07325500",
"title": "Incretin Microdosing for Cardiometabolic Health in People With HIV: The REINFORCE Trial",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07290998",
"publication_url": "https://clinicaltrials.gov/study/NCT07290998",
"title": "A Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Locally Recurrent Prostate Cancer",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Alpha Tau Medical LTD.",
"sponsor_slug": "alpha-tau-medical-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325201",
"publication_url": "https://clinicaltrials.gov/study/NCT07325201",
"title": "Mitigating Diabetic Ketoacidosis in People With T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation Into an Enhanced Glucose Ketone Report",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "HealthPartners Institute",
"sponsor_slug": "healthpartners-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07247162",
"publication_url": "https://clinicaltrials.gov/study/NCT07247162",
"title": "A Double-blind, Randomised, 30-week Placebo-controlled Phase IV Study to Assess the Efficacy and Safety of Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2028-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "RECORDATI GROUP",
"sponsor_slug": "recordati-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00882895",
"publication_url": "https://clinicaltrials.gov/study/NCT00882895",
"title": "Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma",
"has_exemption": false,
"start_date": "2009-05-05",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01950351",
"publication_url": "https://clinicaltrials.gov/study/NCT01950351",
"title": "Phase II Trial of Hypofractionated Proton Beam Therapy in Men With Localized Prostate Adenocarcinoma",
"has_exemption": false,
"start_date": "2013-10-10",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03080974",
"publication_url": "https://clinicaltrials.gov/study/NCT03080974",
"title": "Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2017-08-14",
"completion_date": "2028-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Louisville",
"sponsor_slug": "university-of-louisville",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}